E-submission
KFS
Articles
- Page Path
- HOME > J Musculoskelet Trauma > Volume 33(4); 2020 > Article
- Case Report Sclerotherapy Using Abnobaviscum for the Extensive Recurrent Chronic Morel-Lavallée Lesions - A Case Report -
- Joon-Kuk Kim, Ji-Won Jung, Ki-Chul Park
-
Journal of Musculoskeletal Trauma 2020;33(4):222-226.
DOI: https://doi.org/10.12671/jkfs.2020.33.4.222
Published online: October 31, 2020
- 115 Views
- 4 Download
- 1 Crossref
- 0 Scopus
Abstract
The Morel-Lavallée lesion (MLL) is a closed soft-tissue degloving injury, resulting in characteristic hemo-lymphatic fluid collection between the fascia and subcutaneous layers. The MLL was managed routinely with drainage and compression bandages, but sclerotherapy can be used in patients with chronic lesions refractory to first-line therapy. This paper presents a case of extensive recurrent chronic MLL treated with sclerotherapy using Abnobaviscum, which has been used to treat adhesion in malignant pleural effusion.
J Korean Fract Soc. 2020 Oct;33(4):222-226. Korean.
Published online Oct 22, 2020.
https://doi.org/10.12671/jkfs.2020.33.4.222
Published online Oct 22, 2020.
https://doi.org/10.12671/jkfs.2020.33.4.222
Copyright © 2020 The Korean Fracture Society. All rights reserved.
Case Report
Sclerotherapy Using Abnobaviscum for the Extensive Recurrent Chronic Morel-Lavallée Lesions: A Case Report
Abstract
The Morel-Lavallée lesion (MLL) is a closed soft-tissue degloving injury, resulting in characteristic hemolymphatic fluid collection between the fascia and subcutaneous layers. The MLL was managed routinely with drainage and compression bandages, but sclerotherapy can be used in patients with chronic lesions refractory to first-line therapy. This paper presents a case of extensive recurrent chronic MLL treated with sclerotherapy using Abnobaviscum, which has been used to treat adhesion in malignant pleural effusion.
Keywords
Morel-Lavallée lesion, Pelvic, Sclerotherapy, Abnobaviscum
Figures
Fig. 1
Immediate postoperative radiograph shows the stabilization of a pelvic ring injury, including left acetabular fracture (arrow).
Fig. 2
(A) Magnetic resonance image shows fluid collection (28 cm×5 cm×2 cm; arrow) between the fascia and the subcutaneous layer on postoperative one month. (B, C) After eight months of conservative treatment, magnetic resonance was repeated, showing persistent fluid collection (32 cm×3 cm×6 cm; arrows) with thick enhancing fibrous capsulation.
Fig. 3
(A) Intraoperative appearance of Morel-Lavallée lesion at the left thigh. (B) It was surrounded by thick fibrous capsulation and excised during debridement. (C) The vacuum-assisted closure system was applied to the wound after secondary debridement. (D) After repeated debridement and change in the vacuum-assisted closure system for one week, Abnobaviscum (Abnoba Korea) was administered as a sclerosing agent on an open wound.
Fig. 4
(A) Gross photography of the left thigh. Improved swelling and fluctuation after sclerotherapy. (B, C) After two months of sclerotherapy, a resolved Morel-Lavallée lesion was observed by magnetic resonance imaging.
Notes
Financial support:None.
Conflict of interests:None.
References
-
Parra JA, Fernandez MA, Encinas B, Rico M. Morel-Lavallée effusions in the thigh. Skeletal Radiol 1997;26:239–241.
-
-
Scolaro JA, Chao T, Zamorano DP. The Morel-Lavallée lesion: diagnosis and management. J Am Acad Orthop Surg 2016;24:667–672.
-
-
Luria S, Applbaum Y, Weil Y, Liebergall M, Peyser A. Talc sclerodhesis of persistent Morel-Lavallée lesions (posttraumatic pseudocysts): case report of 4 patients. J Orthop Trauma 2006;20:435–438.
-
-
Letournel E. Fractures of the acetabulum. A study of a series of 75 cases. 1961. Clin Orthop Relat Res 1994;(305):5–9.
-
-
Greenhill D, Haydel C, Rehman S. Management of the Morel-Lavallée lesion. Orthop Clin North Am 2016;47:115–125.
-
-
Shen C, Peng JP, Chen XD. Efficacy of treatment in peri-pelvic Morel-Lavallee lesion: a systematic review of the literature. Arch Orthop Trauma Surg 2013;133:635–640.
-
-
Kilic D, Akay H, Kavukçu S, et al. Management of recurrent malignant pleural effusion with chemical pleurodesis. Surg Today 2005;35:634–638.
-
-
Bansal A, Bhatia N, Singh A, Singh AK. Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions. Injury 2013;44:66–69.
-
-
Ahn HY, Cho JS, Kim YD, et al. Efficacy of mistletoe for chemical pleurodesis in rats without malignancy. Open Med (Wars) 2015;10:346–351.
-
-
Park JB, Lee SA, Lee WS, Kim YH, Hwang JJ. The management of chemical pleurodesis with viscum album in patients with persistent air leakage. J Thorac Dis 2018;10:371–376.
-
Cite
